Home / Inspections / 1009901

FDA Inspection 1009901 — New York Blood Center, Inc.

New York Blood Center, Inc. — FEI 2276020

The FDA completed an inspection of New York Blood Center, Inc. on April 25, 2017 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 25, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New Brunswick, NJ (United States)

Facility

Other inspections at this facility

  • 1194222 (NAI Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1094266 (NAI Mon Jun 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903225 (NAI Fri Nov 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 831324 (NAI Fri May 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 751007 (NAI Wed Oct 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources